Another batch of drugs has gone up in price! Shortage? Over the consistency evaluation?

Medicine network on June 10th, there is a price increase for drugs! on June 6,, the official website of nantong City Health and Health Commission of Jiangsu Province issued a "announcement on adjusting the prices of some drugs shortlisted." according to the, the prices of two drugs were adjusted, namely, nitric glycerin tablets and klinmycin hydrochloric acid capsules, the price adjustment is as follows:The price of nitrate glycerin tablets rose from 0.081 yuan per tablet to 0.313 yuan per tablet, up 286.4%, while the price of klinmycin hydrochloric acid capsules rose from 0.3 yuan per grain to 3.5 yuan per grain, up 1066.6%from the price adjustment of the note, the above-mentioned price increase of the drug nitrate glycerin tablets is a low-cost drug, clineric acid klinmycin capsules are through consistent drugs, it can be seen that their price increases and this factor has a certain linkbelieve that for the nitroglycerin tablets out of stock, price increases, we are no strangersThis year, there have been many media reports on the shortage of nitroglycerin nitrate, out of stock, price increases and other issuesfor example, "Qilu Evening News" recently reported that 19in different regions of Jinan, in February this year only three have 100 pieces of nitric acid tablets in stock, including Jinan Shuyu civilian large drugstore, Pingjia big pharmacy and other large drugstore chains, and all said that years ago has long been out of stockSaiper Blue visited a number of chain pharmacies in Guangzhou also found that, as coronary heart disease and angina patients commonly used drugs of nitric acid glycerin, there has been a case of out-of-stock, some stores even out of stock for up to half a yearhave a pharmacy clerk told Cypress Blue, now nitrate glycerin tablets are generally 15 pieces, the price can be sold to 25 yuan a bottle, the original 100 tablets / bottle is too cheap, it is said that manufacturers have stopped productionnot only pharmacies, but also hospitals, face the same problemReportedly, in principle, the price ofdrugs in public hospitals should not exceed the price of hanging net, but somenitrate glycerin tablet distribution company's purchase price has risen to 30 yuan / box, hanging net price is 23.9 yuan / box (108 pieces), so the publiccan only give up the purchase of domestic medicine, to the price of 99.5 yuan / bottle of imported medicinethis and Nantong City Health and Health Commission on the price of nitroglycerin tablets is not in line According to 108 tablets, the original price is 8.748 yuan, after the price increase of 33.804 yuan is also very concerned about whether the price of will rise by consistency before that, guangxi has a number of hospitals announced the consistency evaluation of drugs, including Guigang City, Chinese and Western medicine combined orthopaedic hospital, Guigang City Chinese medicine hospital, Guangxi Medical University affiliated oncology hospital from the results of the bargaining of these hospitals, even in the same province, the same region, the bargaining of each hospital will have a certain difference, but overall, compared with the previous winning bid, there is still a certain improvement for example, Huahai's Ebeshatan tablets (75mg x 28 pieces), before its winning bid price in Tibet is 40.46 yuan, in Liaoning's winning bid is 42.2 yuan, in the recent hospital bargaining results, in Guigang City, The Chinese and Western medicine combined orthopaedic hospital, Guigang City Chinese medicine hospital, Guangxi Medical University affiliated oncology hospital, the price of 50.94 yuan, 56.56 yuan, 48 yuan, respectively, a small increase in space but compared with the above-mentioned klinmycin capsules, the comparison is still more obvious According to the 10 grain stake in the packaging, the original box as long as 3 yuan, after the price increase of a box has gone to 35 yuan what causes this drug to rise significantly, we do not know, but from the above data we can see that the shortage of drugs, through the consistency of evaluation of drugs, there is a possibility of price increases.